Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China revises GMPs

This article was originally published in The Tan Sheet

Executive Summary

China's State Food and Drug Administration proposes revised good manufacturing practices that would give nonprescription drug firms three years to implement changes once guidelines are issued. Guo Jingwu, director of drug safety in SFDA's Inspection Department, said June 2 at a conference in Shanghai that SFDA adopted the guidelines May 28 and expects to issue the document in June. China's Ministry Of Health is reviewing the guidance and will submit it to the World Trade Organization before releasing it. SFDA will give companies three years to implement changes, though firms that manufacture injection drugs and products on China's Essential Drug List will have two years. The GMP revision, a key goal for SFDA in 2010, is part of the agency's work to align China's pharmaceutical and medical device regulations with international standards (1"The Tan Sheet" March 8, 2010)
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS104172

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel